OpenAI has raised $6.6 billion in a groundbreaking funding round that values the company at $150 billion, setting a new record in Silicon Valley. The San Francisco-based firm, led by CEO Sam Altman, is reportedly asking investors to refrain from backing rival AI startups such as Anthropic and Elon Musk’s xAI.
During negotiations, OpenAI made it clear that they expected exclusive funding arrangements from investors. This strategy aims to limit competitors’ access to capital and strategic partnerships, potentially exacerbating existing tensions with rivals, particularly Musk, who is currently suing OpenAI.
The funding round was led by Thrive, a venture capital firm founded by Joshua Kushner, which committed $750 million from its funds and an additional $550 million from partners. Thrive also retains an option to invest another $1 billion by the end of 2025 at the same valuation. Other notable participants include chipmaker Nvidia (Nasdaq: NVDA), Microsoft (Nasdaq: MSFT), and various venture capital firms and investment entities.
OpenAI’s unprecedented valuation and terms reflect investors’ belief in the company’s potential to dominate the next wave of AI innovation. The company plans to use the new funding to strengthen its leadership in AI research, increase computing capacity, and develop tools for solving complex problems.
However, the deal comes amid recent turmoil at OpenAI, including a brief ousting of Altman last year and the recent departure of Chief Technology Officer Mira Murati. The company is also working on a corporate restructuring that would move it further from its non-profit origins.
The fundraising has stirred controversy, with some viewing OpenAI’s exclusivity demands as unusual in the venture capital world. It has also reignited the ongoing legal dispute with Musk, who alleges that OpenAI has abandoned its original mission to benefit humanity.
Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
